HOPE-Neuron Therapeutx jobs and careers

About HOPE-Neuron Therapeutx

HOPE-Neuron therapeutx is a neurobiology company pioneering a new frontier in the treatment of neurodegenerative diseases—including ALS, MS, and Parkinson’s—via immune system reprogramming. Our proprietary SELanetx™ platform is the world’s first non-drug, non-stem-cell, device-enabled therapy designed to address the root cause of neuroinflammation by restoring immune balance. Designed as a 30-minute therapy, this outpatient blood-processing treatment uses controlled hyperoxia and mechanotransduction to trigger immune rebalancing via a patented M1-to-M2 macrophage shift—transforming “killer” cells into “healer” cells through a natural process called efferocytosis. Unlike traditional pharma approaches focused on symptom management, SELanetx™ teaches the body to heal itself, offering a scalable, repeatable, and durable therapeutic pathway. Preclinical studies show a significant improvement in motor function in ALS mouse models and a confirmed immune system reset, providing a strong proof of concept as we move toward human trials. Backed by global IP across the U.S., Japan, Canada, India, and Australia, and supported by top research institutions including the Indiana University School of Medicine and the Barrow Neurological Institute, HOPE-Neuron is building a defensible, globally scalable business model with recurring revenue potential from treatment regimens and consumables. We are actively preparing for a more advanced next-generation device, regulatory submissions, and expansion into Alzheimer’s and other similar conditions. With a massive unmet clinical need and a total addressable market of up to $68B, Hope- Neuron is not just disrupting the standard of care—we are building a new one. Based in Phoenix, AZ